News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,497 Results
Type
Article (3148)
Company Profile (90)
Press Release (39259)
Section
Business (13955)
Career Advice (63)
Deals (2184)
Drug Delivery (3)
Drug Development (6705)
Employer Resources (14)
FDA (619)
Job Trends (1484)
News (22504)
Policy (1213)
Tag
2027 Genetown Elite (1)
Academia (138)
Accelerated approval (1)
Allergies (6)
Alliances (3570)
ALS (17)
Alzheimer's disease (179)
Antibody-drug conjugate (ADC) (13)
Approvals (653)
Artificial intelligence (42)
Autoimmune disease (18)
Automation (1)
Bankruptcy (18)
Best Places to Work (1143)
Biotechnology (70)
Bladder cancer (1)
Brain cancer (3)
Breast cancer (46)
Cancer (268)
Cardiovascular disease (16)
Career advice (59)
Career pathing (3)
CAR-T (19)
Cell therapy (53)
Cervical cancer (2)
Clinical research (5383)
Collaboration (158)
Company closure (1)
Compensation (123)
Complete response letters (2)
COVID-19 (138)
CRISPR (14)
C-suite (95)
Cystic fibrosis (10)
Data (429)
Depression (6)
Diabetes (8)
Diagnostics (213)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (29)
Drug pricing (1)
Duchenne muscular dystrophy (26)
Earnings (4486)
Editorial (2)
Employer branding (3)
Employer resources (12)
Events (8760)
Executive appointments (94)
FDA (778)
Frontotemporal dementia (4)
Funding (95)
Gene editing (31)
Generative AI (6)
Gene therapy (32)
GLP-1 (32)
Government (122)
Guidances (18)
Healthcare (1183)
Huntington's disease (11)
IgA nephropathy (6)
Immunology and inflammation (18)
Indications (4)
Infectious disease (153)
Inflammatory bowel disease (13)
Influenza (10)
Intellectual property (13)
Interviews (6)
IPO (1305)
Job creations (416)
Job search strategy (57)
Labor market (15)
Layoffs (78)
Legal (182)
Liver cancer (3)
Lung cancer (42)
Lymphoma (3)
Machine learning (2)
Management (2)
Manufacturing (31)
MASH (3)
Medical device (187)
Medtech (188)
Mergers & acquisitions (927)
Metabolic disorders (31)
Multiple sclerosis (5)
Neurodegenerative disease (23)
Neuropsychiatric disorders (2)
Neuroscience (268)
NextGen: Class of 2026 (390)
Non-profit (91)
Now hiring (18)
Obesity (20)
Opinion (10)
Ovarian cancer (10)
Pain (3)
Pancreatic cancer (14)
Parkinson's disease (17)
Patents (22)
Patient recruitment (21)
People (5189)
Pharmaceutical (16)
Phase 1 (2063)
Phase 2 (2418)
Phase 3 (1562)
Pipeline (308)
Postmarket research (94)
Preclinical (1055)
Prostate cancer (6)
Radiopharmaceuticals (22)
Rare diseases (63)
Real estate (638)
Recruiting (8)
Regulatory (1090)
Reports (2)
Research institute (138)
Resumes & cover letters (4)
Rett syndrome (1)
RNA editing (2)
RSV (5)
Schizophrenia (19)
Series A (22)
Series B (9)
Sickle cell disease (19)
Special edition (2)
Spinal muscular atrophy (21)
Sponsored (1)
Startups (480)
Supply chain (2)
Tariffs (2)
Vaccines (44)
Venture capital (7)
Weight loss (2)
Worklife (1)
Date
Last 7 days (33)
Last 30 days (118)
Last 365 days (1876)
2026 (181)
2025 (1918)
2024 (2289)
2023 (2822)
2022 (3542)
2021 (4129)
2020 (3531)
2019 (2795)
2018 (2104)
2017 (2389)
2016 (2319)
2015 (2339)
2014 (1434)
2013 (1164)
2012 (1361)
2011 (1300)
2010 (1290)
Location
Africa (29)
Alaska (1)
Arizona (1)
Asia (1721)
Australia (180)
California (147)
Canada (91)
China (68)
Colorado (8)
Connecticut (6)
Delaware (43)
Europe (8566)
Florida (68)
Georgia (3)
Hawaii (2)
Illinois (14)
India (3)
Indiana (8)
Iowa (2)
Japan (90)
Kentucky (1)
Maryland (19)
Massachusetts (2566)
Michigan (6)
Minnesota (3)
Missouri (1)
Nebraska (2)
New Hampshire (1)
New Jersey (38)
New Mexico (1)
New York (47)
North Carolina (32)
North Dakota (1)
Northern California (91)
Ohio (9)
Oregon (3)
Pennsylvania (19)
Rhode Island (4)
South America (36)
South Carolina (1)
Southern California (32)
Tennessee (1)
Texas (66)
United States (3053)
Utah (6)
Virginia (5)
Washington D.C. (6)
Washington State (133)
Wisconsin (8)
42,497 Results for "cambridge epigenetix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allelica Licenses University of Cambridge BOADICEA Model to Deliver Comprehensive Breast Cancer Risk Assessment
January 22, 2026
·
2 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
October 21, 2025
·
7 min read
Press Releases
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
September 3, 2025
·
4 min read
Press Releases
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
October 28, 2025
·
3 min read
Layoffs
Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of
C. Diff
Drug
Less than six months after cutting 20% of its employees, Vedanta Biosciences has again laid off staff. According to one affected staffer, half of
the Cambridge, Massachusetts–based biotech’s workforce is being cut while most of the rest are furloughed.
January 16, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing
May 20, 2025
·
1 min read
Business
Moderna Moves Cambridge Employees Into New Headquarters
The new Cambridge, Mass.–based facility is about 460,000 square feet. Labs occupy nearly 50% of the space.
April 2, 2024
·
4 min read
·
Angela Gabriel
Press Releases
Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub
June 2, 2025
·
3 min read
Genetown
Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones
SynDevRx, Inc., a pioneering clinical-stage biotechnology company based in Cambridge, Massachusetts, has achieved a significant milestone.
March 28, 2024
·
5 min read
1 of 4,250
Next
